My Watchlist Items
- No Watchlist
Brookline Capital Acquisition Corp. (BCACU)
23.2 13.910001(+149.7309%)
| Title | Name | Pay | Currency Pay | Gender | Year Born | Title Since |
|---|---|---|---|---|---|---|
| Chief Financial Officer | Mr. Patrick Sturgeon | N/A | USD | male | N/A | N/A |
| Pres & Director | Mr. Scott A. Katzmann | N/A | USD | male | N/A | N/A |
| Chairman & Chief Executive Officer | Dr. Samuel P. Wertheimer Ph.D. | N/A | USD | N/A | N/A |
| Holder | Shares | Date Reported | Change |
|---|---|---|---|
| UBS GROUP AG | 1050 | 30 June, 2022 | -324 |
| YAKIRA CAPITAL MANAGEMENT, INC. | 170000 | 31 March, 2022 | 0 |
| HRT FINANCIAL LP | 20425 | 31 March, 2022 | 0 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 119 | 31 March, 2022 | -2 |
| WALLEYE CAPITAL LLC | 18917 | 31 March, 2022 | 18917 |
| CLEARSTEAD ADVISORS, LLC | 100 | 31 March, 2022 | 0 |
| Symbol | Transaction Date | Reporting Cik | Securities Owned | Company Cik | Reporting Name | Acquistion Or Disposition | Form Type | Securities Transacted | Security Name | Link |
|---|---|---|---|---|---|---|---|---|---|---|
| BCACU | 11 February, 2021 | 0001076809 | 225000 | 0001814140 | GLAZER CAPITAL, LLC | D | 4 | 400000 | Units | View |
| BCACU | 2 February, 2021 | 0001814664 | 1627000 | 0001814140 | Brookline Capital Holdings LLC | A | 4 | 247000 | Common Stock | View |
| Symbol | Date | Period | Download XLSX File |
|---|---|---|---|
| BCACU | 2021 | Q3 | Download XLSX File |
| BCACU | 2021 | Q2 | Download XLSX File |
| BCACU | 2021 | Q1 | Download XLSX File |
Charts
Company Profile
Company Name Brookline Capital Acquisition Corp.
Symbol BCACU
Currency USD
Price 23.2
Exchange Name NASDAQ Capital Market (NASDAQ)
Industry Shell Companies
CEO James Jiayuan Tong
Sector Financial Services
Country US
Zip 10017
Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
